{
    "organizations": [],
    "uuid": "f9836adecb9ad22f3616025b615c844333a0624b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cipher-pharmaceuticals-acquires-ex/brief-cipher-pharmaceuticals-acquires-exclusive-canadian-rights-to-fda-approved-trulance-from-synergy-pharma-idUSFWN1QI0TN",
    "ord_in_thread": 0,
    "title": "BRIEF-Cipher Pharmaceuticals Acquires Exclusive Canadian Rights To FDA-Approved Trulance® From Synergy Pharma",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 28 (Reuters) - Cipher Pharmaceuticals Inc:\n* CIPHER PHARMACEUTICALS ACQUIRES EXCLUSIVE CANADIAN RIGHTS TO FDA-APPROVED TRULANCE® FROM SYNERGY PHARMACEUTICALS\n* CIPHER PHARMACEUTICALS INC - ‍UNDER TERMS OF LICENSING AGREEMENT, SYNERGY WILL RECEIVE AN UPFRONT PAYMENT OF US$5.0 MILLION​\n* CIPHER - ‍UNDER TERMS OF LICENSING AGREEMENT, SYNERGY ELIGIBLE FOR ADDITIONAL MILESTONE PAYMENT, & ROYALTIES FROM PRODUCT SALES IN CANADA​\n* CIPHER PHARMACEUTICALS INC - ‍AGREEMENT PROVIDES THAT SYNERGY WILL BE RESPONSIBLE FOR MANUFACTURING AND SUPPLYING FINISHED PRODUCT TO CO Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)\n ",
    "published": "2018-02-28T20:11:00.000+02:00",
    "crawled": "2018-03-01T21:03:54.052+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "cipher",
        "pharmaceutical",
        "inc",
        "cipher",
        "pharmaceutical",
        "acquires",
        "exclusive",
        "canadian",
        "right",
        "synergy",
        "pharmaceutical",
        "cipher",
        "pharmaceutical",
        "inc",
        "term",
        "licensing",
        "agreement",
        "synergy",
        "receive",
        "upfront",
        "payment",
        "u",
        "cipher",
        "term",
        "licensing",
        "agreement",
        "synergy",
        "eligible",
        "additional",
        "milestone",
        "payment",
        "royalty",
        "product",
        "sale",
        "cipher",
        "pharmaceutical",
        "inc",
        "provides",
        "synergy",
        "responsible",
        "manufacturing",
        "supplying",
        "finished",
        "product",
        "co",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}